Search

everythinglearnresearchcommunity

for

Search:↓

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.

The document is a detailed medical reference on skin and genetic disorders.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

The document explains various skin conditions and their treatments.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Hydrogels show promise for scarless wound healing by reducing skin fibrosis.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

EpiLife® media and younger donor age improve artificial skin model quality.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.